Q BioMed Inc. (QBIO)
Stock Price: $1.07 USD
0.00 (0.00%)
Updated December 2, 4:00 PM EST - Market closed
QBIO Stock Price Chart
Key Info
| Market Cap | 25.05M |
| Revenue (ttm) | 30,000 |
| Net Income (ttm) | -13.25M |
| Shares Out | 22.43M |
| EPS (ttm) | -0.65 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
Stock Quote
| Trading Day | December 2 |
| Last Price | $1.07 |
| Previous Close | $1.07 |
| Change ($) | 0.00 |
| Change (%) | 0.00% |
| Day's Open | 1.08 |
| Day's Range | 1.07 - 1.10 |
| Day's Volume | 18,536 |
| 52-Week Range | 0.00 - 1.10 |
QBIO Stock News
There are no news items available yet.
About QBIO
Q BioMed, a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride SR89, a radiopharmaceutical therapeutic for the treatment of bone cancer pain therapies; and Metastron, a radiopharmaceutical drug for metastatic cancer bone pain therapy. It is also developing Man-01, a pre-clinical lead candidate for the treatment of primary open angle glaucoma; QBM-001 for rare pediatric non-verbal autism spectrum disorder; and U... [Read more...]
| Industry Biotechnology | Founded 2013 |
| Employees 1 | |
| Stock Exchange US OTC | Ticker Symbol QBIO |
Analyst Forecasts
The average 12-month stock price forecast for Q BioMed is 6.00, which is an increase of 460.75% from the latest price.
Price Target
$6.00
(460.75% upside)